Lupin Downgrade to HOLD from Buy with PT of Rs1,849

Discussion in 'Ask A Query About Your Stock Picks And Portfolio' started by Vidhi Khanna, Mar 20, 2015.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    760
    Likes Received:
    55
    Lupin receives tentative approval for g-Celebrex (100mg, 200mg and 400mg); Downgrade to HOLD from Buy with PT of Rs1,849 (from Rs1,777 earlier) | Lupin has received tentative approval for g-Celebrex with concentration of 100mg, 200mg and 400mg. Lupin had received final approval for 50mg celecoxib capsules in November 2014. Celecoxib are indicated for osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older; ankylosing spondylitis, and acute pain. (IndiaNivesh)
     
Loading...